The Patent Finder

Institut Claudius Regaud

4 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 28, 2027
    The maintenance fee for Anti-Rho Gtpase Conformational Single Domain Antibodies and Uses Thereof (US 10,544,210) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,144,772New Method for Treating Melanoma
In force
 · High confidence
In forceHigh confidence
US 10,544,210Anti-Rho Gtpase Conformational Single Domain Antibodies and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,186,634Antibodies Targeting Tumor Associated Macrophages and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 12,740,979Methods for the Treatment of Cancers That Have Acquired Resistance to Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 2 no status recorded

Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/856,328Combination of Ras Inhibitors and Farnesyltransferase Inhibitors for the Treatment of CancersApr 27, 2023Pending
17/700,624Anti-Rho Gtpase Conformational Single Domain Antibodies and Uses ThereofMar 22, 2022Abandoned
18/257,383Diagnostic Method for Cancer Evolution Prediction, and Uses ThereofDec 13, 2021Pending
17/593,474Mar 19, 2020No status recorded
10/548,567Mar 12, 2004No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited